Bipolar Disorder Treatment Medications Using Atypical Antipsychotics for Treatments By Marcia Purse Marcia Purse Marcia Purse is a mental health writer and bipolar disorder advocate who brings strong research skills and personal experiences to her writing. Learn about our editorial process Updated on March 03, 2021 Medically reviewed Verywell Mind articles are reviewed by board-certified physicians and mental healthcare professionals. Medical Reviewers confirm the content is thorough and accurate, reflecting the latest evidence-based research. Content is reviewed before publication and upon substantial updates. Learn more. by Steven Gans, MD Medically reviewed by Steven Gans, MD Steven Gans, MD is board-certified in psychiatry and is an active supervisor, teacher, and mentor at Massachusetts General Hospital. Learn about our Medical Review Board Print Nenov / Moment / Getty Images Antipsychotic drugs are designed to treat a severe psychiatric condition known as psychosis. Psychosis is characterized by the distortion of thoughts during which a person loses touch with reality, often manifesting with hallucinations, delusions, or disorganized thinking. Psychosis has long been treated with a class of drugs known as typical antipsychotics. These were first developed in the 1950s and, while effective, are known to cause Parkinson-like side effects. Today, a newer class of medication known as atypical antipsychotics are commonly used. These were introduced in the 1980s and boast a different side effect profile with far fewer of the Parkinson-like and other movement effects compared to the older agents. Atypical antipsychotics are commonly referred to as second-generation antipsychotics, while typical psychotics are called first-generation antipsychotics. Atypical vs. Typical Antipsychotics Typical and some atypical antipsychotics are dopamine antagonists, which means that they impede chemical messengers in the brain known as dopamine. In people with psychosis, dopamine signals are typically abnormal. Antipsychotics block those messages. Atypical antipsychotics also influence a chemical messenger known as serotonin. Atypical antipsychotics are most typically prescribed to treat schizophrenia and to augment the treatment of major depressive disorder (MDD), bipolar disorder, and schizoaffective disorder. Side Effects of Antipsychotics The two classes of drugs differ in the range and severity of side effects they can cause. Comparatively speaking: Atypical antipsychotics: These are far less likely to cause extrapyramidal side effects. With that being said, they are known to cause weight gain, metabolic problems, and sexual side effects, among others. Typical antipsychotics: These are more likely to cause extrapyramidal side effects in which motor control is sometimes severely impaired, causing tremors, spasms, muscle rigidity, and the loss of control and coordination of muscle movement. In some cases, the symptoms may become permanent even after the treatment is stopped. Black Box Warning All antipsychotics (atypical and typical) carry a black box warning due to an increased risk of death in older adults with dementia-related psychosis. The increased mortality is mostly due to cardiovascular events (heart failure, sudden death) and infections (pneumonia). Types of Atypical Antipsychotic There are many different atypical antipsychotics used to treat psychotic episodes of schizophrenia, bipolar disorder, and other mental illnesses. Among them: Abilify (aripiprazole): This is used in the treatment of schizophrenia and bipolar disorder but may also be used in the treatment of major depressive disorder (MDD). Side effects include weight gain, headache, agitation, anxiety, insomnia, nausea, constipation, and lightheadedness. Clozaril (clozapine): The preferred option for treatment-resistant schizophrenia, Clozaril may decrease suicidal behavior. Serious side effects can include agranulocytosis (a dangerous drop in white blood cells) and acute myocarditis (heart inflammation). Geodon (ziprasidone): This is used to treat schizophrenia and either a manic or mixed episode of bipolar disorder. It has also been used off-label to treat post-traumatic stress disorder (PTSD). The drug has been known to cause dizziness, arrhythmia (irregular heartbeat), and postural hypotension (a drop in blood pressure when standing). Invega (paliperidone): This is used to treat schizophrenia but is also the only oral atypical antipsychotic with a formal FDA indication to treat schizoaffective disorder. Invega may also cause restlessness, weight gain, and sedation. Risperdal (risperidone): This is used to treat schizophrenia, bipolar disorder, and irritability associated with autism. While less sedating than some of the other atypical antipsychotics, Risperdal tends to have more extrapyramidal side effects. Seroquel (quetiapine): Used to treat schizophrenia, bipolar, and other mood disorders, Seroquel is often used off-label to treat insomnia due to its potent sedative effect. When compared to the other antipsychotic drugs, Seroquel has a lower incidence of motor side effects but may cause weight gain, and postural hypertension. Zyprexa (olanzapine): This is used to treat schizophrenia and bipolar disorder. Zyprexa can also cause significant weight gain as well as high blood sugar (increasing the risk of insulin resistance and diabetes). With that being said, Zyprexa has a lower rate of extrapyramidal effects than most of the other atypical antipsychotics. There continue to be new atypical antipsychotics reaching the market for the treatment of psychotic and mood disorders. These include: Saphris (asenapine) Fanapt (iloperidone) Latuda (lurasidone) Rexulti (brexpiprazole) Vraylar (cariprazine) Caplyta (lumateperone) Sources Verywell Mind uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Fornaro M, Stubbs B, De Berardis D, et al. Atypical antipsychotics in the treatment of acute bipolar depression with mixed features: a systematic review and exploratory meta-analysis of placebo-controlled clinical trials. IJMS. 2016;17(2):241. doi:10.3390/ijms17020241 Kishimoto T, Agarwal V, Kishi T, Leucht S, Kane JM, Correll CU. Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics. Mol Psychiatry. 2013;18(1):53-66. doi:10.1038/mp.2011.143 Rummel-Kluge C, Komossa K, Schwarz S, et al. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis. Schizophrenia Research. 2010;123(2-3):225-233. doi:10.1016/j.schres.2010.07.012 By Marcia Purse Marcia Purse is a mental health writer and bipolar disorder advocate who brings strong research skills and personal experiences to her writing. See Our Editorial Process Meet Our Review Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit Speak to a Therapist Online Advertiser Disclosure × The offers that appear in this table are from partnerships from which Verywell Mind receives compensation.